SCHEMBL1629044

SCHEMBL1629044

Nc1cccc(-n2nccc2-c2cc(Br)c(O)cc2O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.40
TSHR P16473 1/20 0.37
NR3C2 P08235 4/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.33
PTGER1 P34995 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
CYP2C8 P10632 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C18 P33260 1/20 0.32
CYP2C19 P33261 1/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630049 0.84 NR3C2 (0.46) HSP90AA1NR3C2MAPTALDH1A1KMT2A
SCHEMBL27675363 0.84 HSP90AA1 (0.45) HSP90AA1NR3C2PTGER1
SCHEMBL1630410 0.81 ALDH1A1 (0.40) HSP90AA1TSHRNR3C2MAPTPOLB
SCHEMBL1628677 0.77 HSP90AA1 (0.51) HSP90AA1TSHRNR3C2POLBKDM4E
SCHEMBL1631616 0.77 HSP90AA1 (0.44) HSP90AA1NR3C2MAPTMEN1ALDH1A1
SCHEMBL1630434 0.72 HSP90AA1 (0.60) HSP90AA1NR3C2MAPTMEN1ALDH1A1
SCHEMBL27675342 0.71 HSP90AA1 (0.42) HSP90AA1NR3C2MAPTPOLBPTGER1
SCHEMBL1630156 0.70 HSP90AA1 (0.49) HSP90AA1NR3C2ALDH1A1ESR1ESR2
SCHEMBL13522939 0.70 HSP90AA1 (0.51) HSP90AA1TSHRNR3C2MAPTPOLB
SCHEMBL1628980 0.69 NT5E (0.44) HSP90AA1PTGER1MAPK9MAPK10ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
CN-101006061-A 1,5-diphenylpyrazoles MERCK PATENT GMBH (DE) 2007-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885TSHR 1658/4885NR3C2 558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.